Monday - Friday, 6:00 - 7:00 PM ET Abbott Laboratories CEO Robert Ford unpacked his company's latest quarterly report in a Thursday interview with CNBC's Jim Cramer, saying that Wall Street's reaction ...

Abbott Laboratories (ABT) is bracing for the impact of higher tariffs, including a 50% US levy on its Indian imports. "Our impact between the whole network is just under $200 million," CEO Robert Ford ...

Abbott Laboratories’ stock took a direct hit, wiping out nearly 10% of its market value following its Q4 earnings. Response? The CEO bought $2 million shares. Robert B. Ford, CEO of Abbott ...

"I think this is a little bit of an overreaction. Of course, we are all over this," Ford said. "We're focused on this, but the fundamentals of the entire rest of the company are pretty much intact, ...